Kilovoltage peak
Kilovoltage peak (kVp) is the peak potential applied to the x-ray tube, which accelerates electrons from the cathode to the anode in radiography or computed tomography. Tube voltage, in turn, determines the quantity and quality of the photons generated. An increase in kVp extends and intensifies the x-ray emission spectrum, such that the maximal and average/effective energies are higher and the photon number/intensity is higher.
Along with the mAs (tube current and exposure time product) and filtration, kVp (tube voltage) is one of the primary settings that can be adjusted on x-ray machines to control the image quality and patient dose.
Image quality
The first consideration when selecting the kVp is ensuring adequate penetration and exposure 5,7, which depends on photon number, photon energy, and tissue attenuation (which depends on attenuation coefficient and thickness). There must be an adequate number of sufficiently energetic photons that penetrate the patient and reach the image receptor. Exposure at the image receptor increases approximately by the fifth power of the change in kVp (due to a combination of increased photon number and penetrability), such that a 15% increase in kVp doubles the intensity at the detector 7,8. Particularly in larger body parts, such as obese adult torsos, lower energy photons are absorbed completely without contributing to image formation. In such situations, higher kVp is employed to improve the x-ray intensity reaching the receptor, thus increasing the signal to noise ratio on the images.
Once sufficient exposure is ensured, the next consideration for adjusting kVp is image contrast. At higher photon energies, photoelectric effect interactions are less frequent, so a higher proportion of photon interactions are Compton scatter, which varies less between different tissues than the photoelectric effect does. Moreover, higher energy photons are more likely to travel through the patient without any tissue interaction. Consequently, higher energy x-ray beams generate images with poorer contrast 6.
Dose
When given satisfactory penetration and contrast, the radiation dose to the patient must also be considered when setting the kVp. Photon quantity output is approximately proportional to a power function, kVpn, where n is approximately 2 in radiography and 2.6 in CT (with the variation related to differences in filtration and beam shape) 3,4. For example, an increase from 100 to 120 kVp would increase CT dose index by more than 50% if other parameters were held constant.
In reality, so as to not increase dose unnecessarily, the mAs setting is typically adjusted down to compensate for the increased photon quantity caused by increasing kVp. Modern digital imaging systems achieve this through automated methods. As the fifth-power rule of thumb goes 7, to maintain the same image receptor exposure, every 15% change in kVp should be accompanied by an inverse adjustment in mAs by a factor of 2.
The ability to reduce mAs by a fifth-power relation is more than adequate to balance the second to third power direct effect of increasing kVp on photon quantity. The difference is related to how the probability of energy absorption in various biologic tissues declines dramatically over the range of photon energies used for diagnostic imaging 9. Thus, absorbed dose can be reduced while keeping the image receptor exposure constant by choosing a higher kVp and lower mAs. As this reduction is achieved with higher energy photons, however, the tradeoff is lower image contrast. Lower kVp techniques may be employed at lower dose when contrast is more important (e.g. CT angiography of the abdomen 10) or when noise related to attenuation is less of a problem (e.g. children 11).
Related Radiopaedia articles
Imaging technology
- imaging technology
- imaging physics
- imaging in practice
-
x-ray
- x-ray physics
- x-ray in practice
- x-ray production
- x-ray tubes
- tube rating
- filters
- automatic exposure control (AEC)
- beam collimators
- grids
- air gap technique
- cassette
- intensifying screen
- x-ray film
- image intensifier
- digital radiography
- digital image
- mammography
- x-ray artifacts
- radiation units
- radiation safety
- radiation detectors
- fluoroscopy
-
computed tomography (CT)
- CT physics
- CT in practice
- CT technology
- CT image reconstruction
- CT image quality
- CT dose
- CT contrast media
-
CT artifacts
- patient-based artifacts
- physics-based artifacts
- hardware-based artifacts
- ring artifact
- tube arcing
- out of field artifact
- air bubble artifact
- helical and multichannel artifacts
- CT safety
- history of CT
-
MRI
- MRI physics
- MRI in practice
- MRI hardware
- signal processing
-
MRI pulse sequences (basics | abbreviations | parameters)
- T1 weighted image
- T2 weighted image
- proton density weighted image
- chemical exchange saturation transfer
- CSF flow studies
- diffusion weighted imaging (DWI)
- echo-planar pulse sequences
- fat-suppressed imaging sequences
- gradient echo sequences
- inversion recovery sequences
- metal artifact reduction sequence (MARS)
-
perfusion-weighted imaging
- techniques
- derived values
- saturation recovery sequences
- spin echo sequences
- spiral pulse sequences
- susceptibility-weighted imaging (SWI)
- T1 rho
- MR angiography (and venography)
-
MR spectroscopy (MRS)
- 2-hydroxyglutarate peak: resonates at 2.25 ppm
- alanine peak: resonates at 1.48 ppm
- choline peak: resonates at 3.2 ppm
- citrate peak: resonates at 2.6 ppm
- creatine peak: resonates at 3.0 ppm
- functional MRI (fMRI)
- gamma-aminobutyric acid (GABA) peak: resonates at 2.2-2.4 ppm
- glutamine-glutamate peak: resonates at 2.2-2.4 ppm
- Hunter's angle
- lactate peak: resonates at 1.3 ppm
- lipids peak: resonates at 1.3 ppm
- myoinositol peak: resonates at 3.5 ppm
- MR fingerprinting
- N-acetylaspartate (NAA) peak: resonates at 2.0 ppm
- propylene glycol peak: resonates at 1.13 ppm
-
MRI artifacts
- MRI hardware and room shielding
- MRI software
- patient and physiologic motion
- tissue heterogeneity and foreign bodies
- Fourier transform and Nyquist sampling theorem
- MRI contrast agents
- MRI safety
-
ultrasound
- ultrasound physics
-
transducers
- linear array
- convex array
- phased array
- frame averaging (frame persistence)
- ultrasound image resolution
- imaging modes and display
- pulse-echo imaging
- real-time imaging
-
Doppler imaging
- Doppler effect
- color Doppler
- power Doppler
- B flow
- color box
- Doppler angle
- pulse repetition frequency and scale
- wall filter
- color write priority
- packet size (dwell time)
- peak systolic velocity
- end-diastolic velocity
- resistive index
- pulsatility index
- Reynolds number
- panoramic imaging
- compound imaging
- harmonic imaging
- elastography
- scanning modes
- 2D ultrasound
- 3D ultrasound
- 4D ultrasound
- M-mode
-
ultrasound artifacts
- acoustic shadowing
- acoustic enhancement
- beam width artifact
- reverberation artifact
- ring down artifact
- mirror image artifact
- side lobe artifact
- speckle artifact
- speed displacement artifact
- refraction artifact
- multipath artifact
- anisotropy
- electrical interference artifact
- hardware-related artifacts
- Doppler artifacts
- aliasing
- tissue vibration
- spectral broadening
- blooming
- motion (flash) artifact
- twinkling artifact
- acoustic streaming
- biological effects of ultrasound
- history of ultrasound
-
nuclear medicine
- nuclear medicine physics
- detectors
- tissue to background ratio
-
radiopharmaceuticals
- fundamentals of radiopharmaceuticals
- radiopharmaceutical labeling
- radiopharmaceutical production
- nuclear reactor produced radionuclides
- cyclotron produced radionuclides
- radiation detection
- dosimetry
- specific agents
- carbon-11
- chromium-51
- fluorine agents
- gallium agents
- Ga-67 citrate
- Ga-68
- iodine agents
-
I-123
- I-123 iodide
- I-123 ioflupane (DaTSCAN)
- I-123 ortho-iodohippurate
- I-131
-
MIBG scans
- I-123 MIBG
- I-131 MIBG
-
I-123
- indium agents
- In-111 Octreoscan
- In-111 OncoScint
- In-111 Prostascint
- In-111 oxine labeled WBC
- krypton-81m
- nitrogen-13
- oxygen-15
- phosphorus-32
- selenium-75
-
technetium agents
- Tc-99m DMSA
- Tc-99m DTPA
- Tc-99m DTPA aerosol
- Tc-99m HMPAO
- Tc-99m HMPAO labeled WBC
- Tc-99m MAA
- Tc-99m MAG3
- Tc-99m MDP
- Tc-99m mercaptoacetyltriglycine
- Tc-99m pertechnetate
- Tc-99m labeled RBC
- Tc-99m sestamibi
- Tc-99m sulfur colloid
- Tc-99m sulfur colloid (oral)
- thallium-201 chloride
- xenon agents
- in vivo therapeutic agents
- pharmaceuticals used in nuclear medicine